New Pharmaceuticals

From: Updated: 2016-12-15

In 2014, the output value was 44.94 billion yuan. Representative enterprises include Hengrui, Hansoh, Kanion and Chia-tai Tianqing. Encouraged investment fields: innovative drugs including new type anti-tumor drugs, anti-hepatitis drugs, cardiovascular drugs, anti-virus drugs, neurological and mental drugs, TCM, natural medicine, medical devices and medical packages, biomedicines and marine medicines.